Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting for the Quarter Ended March 31, 2025


	Treatment			Services			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	9,186		$	4,733		$	13,919		$	—		$	13,919
Cost of Goods Sold:
Payroll and benefits expenses		4,437			2,013			6,450			—			6,450
Material and supplies expenses		1,351			—			1,351			—			1,351
Disposal expenses		220			—			220			—			220
Transportation expenses		495			—			495			—			495
Subcontract expenses		—			908			908			—			908
Other cost of goods sold ⁽²⁾		2,433			1,405			3,838			—			3,838
Total cost of goods sold		8,936			4,326			13,262			—			13,262
Gross profit		250			407			657			—			657
Selling, general and administrative expenses (“SG&A”):
Payroll and benefits		873			538			1,411			931			2,342
Other SG&A ⁽³⁾		483			198			681			992			1,673
Total SG&A		1,356			736			2,092			1,923			4,015
Research and development		291			23			314			69			383
Gain on disposal of property and equipment		—			(5	)		(5	)		—			(5	)
Loss from operations	$	(1,397	)	$	(347	)	$	(1,744	)	$	(1,992	)		(3,736	)
Interest income														335
Interest expense														(112	)
Interest expense-financing fees														(20	)
Other income														33
Loss from continuing operations before taxes														(3,500	)
Income tax expense														—
Loss from continuing operations, net of taxes													$	(3,500	)

Segment Reporting for the quarter ended March 31, 2024


	Treatment			Services			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	8,709		$	4,908		$	13,617		$	—		$	13,617
Cost of goods sold:
Payroll and benefit expenses		3,751			2,452			6,203			—			6,203
Material and supplies expenses		763			—			763			—			763
Disposal expenses		1,569			—			1,569			—			1,569
Transportation expenses		298			—			298			—			298
Subcontract expenses		—			1,810			1,810			—			1,810
Other cost of goods sold ⁽²⁾		2,380			1,214			3,594			—			3,594
Total cost of goods sold		8,761			5,476			14,237			—			14,237
Gross loss		(52	)		(568	)		(620	)		—			(620	)
SG&A:
Payroll and benefits		670			655			1,325			834			2,159
Other SG&A ⁽³⁾		395			137			532			853			1,385
Total SG&A		1,065			792			1,857			1,687			3,544
Research and development		218			28			246			50			296
Loss from operations	$	(1,335	)	$	(1,388	)	$	(2,723	)	$	(1,737	)		(4,460	)
Interest income														174
Interest expense														(116	)
Interest expense-financing fees														(13	)
Other income														1
Loss from continuing operations before taxes														(4,414	)
Income tax benefit														(956	)
Loss from continuing operations, net of taxes													$	(3,458	)

⁽¹⁾	Amounts reflect the activity for corporate headquarters not included in the segment reporting information.

⁽²⁾	Other cost of goods sold for each reportable segment includes:
	Treatment - lab, regulatory, maintenance, depreciation and amortization, travel, outside services and general expenses. Services - material and supplies, disposal, transportation, lab, regulatory, maintenance, depreciation and amortization, travel, outside services and general expenses.

⁽³⁾	Other SG&A for each reportable segment and Corporate includes:
	Treatment-depreciation and amortization, travel, outside services, maintenance and general expenses.
	Services- travel, outside services, maintenance and general expenses.
	Corporate-maintenance, depreciation and amortization, travel, public company, outside services and general expenses.

The following table presents depreciation and amortization for the three months ended March 31, (in thousand):